FDA inspection
Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd: FDA inspection ending Jul 14, 2017
FDA inspection 1021861 · No Action Indicated (NAI) · Shijiazhuang
Key facts
| Inspection ID | 1021861 |
|---|---|
| Firm | Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd |
| FEI number | 3010066204 |
| Address | No 16 Xihuan Road, Shenze |
| City | Shijiazhuang |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | Jul 14, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data